Company History and Legal Base
The research group based on privately owned medical consulting and research company, MEDIX that has been established in 1991, with an expanded network of clinical research partners and academic professionals in multiple therapeutic areas we providing a solid base for coverage across the countries.
MEDIX has been involved by an international CRO Partnership to establish a solid and reliable base of clinical monitoring and consultancy hub first in Hungary and then by gradual expansion to other Central-EU countries (HU, SK, CZ, SL). The network of operation has the territorial coverage for all the three main regions also included Balkan Peninsula (RO, MLD, BG, GR), the West- Balkan countries (HR, SR, MD, BiH) and currently under the development for extended region to Israel, Russia and the CIS countries.
MEDIX services has been expanded with the consultancy portfolio since 2000, providing medical writing supporting services for product registration, materials and later on applications for national and DCP Marketing Authorization procedures.
MEDIX has been involved managing projects in applied medical science, developing medical devices for diagnostic and rehabilitation purposes, and (nonclinical) drug research. The projects supported by national and EU research grants.
Our vision is to provide personalized services to establish rational solutions with quality, when managing projects to support medical science, throughout the drug development process, via established relationship with partners of academic and research professionals.
The clients range from small to medium sized pharmaceutical and biopharmaceutical companies, device companies, academic hospitals and university clinics. MEDIX has been established partnership with international or local CROs, providing regional coverage of services.
MEDIX regional clinical operational and start-up team experiences: Phase-II/III – in multiple therapeutic areas Phase III b/IV and Non-Interventional Trials – in multiple therapeutic areas Phase I/ Phase II/a and BE projects for specific therapeutic areas
Our local experience and clinical trials services covers the CEE and West-Balkan countries and recently under the development with ISR, RUS, UKR, and the CIS countries.